Literature DB >> 2536526

The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.

R Hällgren1, L Bjermer, R Lundgren, P Venge.   

Abstract

The number of eosinophils and the concentrations of eosinophil cationic protein (ECP), a specific granule constituent of eosinophil granulocytes, were measured in bronchoalveolar lavage (BAL) fluid from patients (n = 22) with idiopathic pulmonary fibrosis (IPF). The median recovery of eosinophils during lavage performance was 4% (range, zero to 49) of the nonepithelial cells and significantly increased compared with the recovery in healthy control subjects (less than 1%) and in control patients with sarcoidosis (1%; range, zero to 7). The median BAL fluid concentration of ECP was in IPF 13.3 micrograms/L (range, 2 to 118) and significantly increased compared with the concentrations in healthy control subjects (2.7 micrograms/L; range, less than 2 to 8) and in control patients (6.6 micrograms/L; range, less than 2 to 64). The BAL fluid concentrations of myeloperoxidase (MPO) were also significantly increased in IPF, indicating a local neutrophil activation. A significant correlation was found between BAL fluid ECP and MPO, suggesting a common activator of eosinophils and neutrophils. BAL fluid eosinophils and ECP correlated with the reduced diffusion capacity of the lung but not with vital capacity or forced expiratory volume. It is concluded that eosinophil activation is part of the inflammatory process in IPF. ECP and other cytotoxic eosinophil products may play a pathophysiologic role for the lung damage in this disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536526     DOI: 10.1164/ajrccm/139.2.373

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  27 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 3.  Eosinophils and disease pathogenesis.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

4.  Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).

Authors:  Dianne M Walters; Kevin M White; Ushma Patel; Martin J Davis; Roberta M Veluci-Marlow; Solomon Raju Bhupanapadu Sunkesula; James C Bonner; Jessica R Martin; Wes Gladwell; Steven R Kleeberger
Journal:  FASEB J       Date:  2013-11-27       Impact factor: 5.191

Review 5.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

6.  A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis.

Authors:  Eva Morschl; Jose G Molina; Jonathan B Volmer; Amir Mohsenin; Ralph S Pero; Jeong-Soo Hong; Farrah Kheradmand; James J Lee; Michael R Blackburn
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

7.  The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.

Authors:  U Zagai; C M Sköld; A Trulson; P Venge; J Lundahl
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

Authors:  R Hällgren; B Gudbjörnsson; E Larsson; K Fredens
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

9.  Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts.

Authors:  T P Birkland; M D Cheavens; S H Pincus
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

10.  Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia.

Authors:  A Janin; G Torpier; P Courtin; M Capron; L Prin; A B Tonnel; P Y Hatron; B Gosselin
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.